News

Study evaluates novel and traditional antifungal agents to determine efficacy.

Employees of medical marijuana dispensaries advocate drug’s benefits, contradicting the position of the American Glaucoma Society.

In our latest episode, Laura M. Periman, MD, shares her experience using intense pulsed light (IPL) therapy, and the benefits she's found in it for treating patients with chalazion.

Eye issues may have been factor for historic military leader

No cookie-cutter procedure, UEB can improve patients’ visual fields by more than 25%

Short drive times, access to transportation play role in maintaining eye health appointments

Sixty-five genes identified with several belonging to signaling pathways

Here's how hospital stays can affect vision

JAMA Ophthalmology investigates the accuracy claims of this convenient modality 

Voting for the 2019 Ophthalmology Times Resident Writers Award Program is now open!

Our supply of dorzolamide, long a first-line glaucoma therapy used alone or in fixed combination with timolol, has recently proven unreliable.

Operating a small practice may require physicians to wear many hats

Supplementation no better than placebo as results confirm previous research

Impact far-reaching from patients to residency training

New compounds could offer more options for physicians in treating patients, leading to better outcomes. 

Dual-plane blepharoplasty can improve tear trough, skin, lower lid position

Research does not support routine use to decrease the risk of PCME

Study compares preoperative risk factors, co-pathology in patients

Established in other areas, telemedicine implementation slow in glaucoma treatment

Capitated health-care models may be best positioned to take advantage of telehealth